Universal Ibogaine Inc. (IBOGF)

USD 0.02

(0.0%)

Net Income Summary of Universal Ibogaine Inc.

  • Universal Ibogaine Inc.'s latest annual net income in 2022 was -10.49 Million CAD , down -171.41% from previous year.
  • Universal Ibogaine Inc.'s latest quarterly net income in 2023 Q3 was -486.59 Thousand CAD , up 38.63% from previous quarter.
  • Universal Ibogaine Inc. reported an annual net income of -3.86 Million CAD in 2021, down -3168.74% from previous year.
  • Universal Ibogaine Inc. reported an annual net income of -118.3 Thousand CAD in 2020, down -20.59% from previous year.
  • Universal Ibogaine Inc. reported a quarterly net income of -841.96 Thousand CAD for 2023 Q1, up 87.15% from previous quarter.
  • Universal Ibogaine Inc. reported a quarterly net income of -486.59 Thousand CAD for 2023 Q3, up 38.63% from previous quarter.

Annual Net Income Chart of Universal Ibogaine Inc. (2022 - 2018)

Historical Annual Net Income of Universal Ibogaine Inc. (2022 - 2018)

Year Net Income Net Income Growth
2022 -10.49 Million CAD -171.41%
2021 -3.86 Million CAD -3168.74%
2020 -118.3 Thousand CAD -20.59%
2019 -98.1 Thousand CAD 75.97%
2018 -408.28 Thousand CAD 0.0%

Peer Net Income Comparison of Universal Ibogaine Inc.

Name Net Income Net Income Difference
Bioxytran, Inc. -4.28 Million USD -145.238%
Eiger BioPharmaceuticals, Inc. -74.96 Million USD 85.998%
Institute of Biomedical Research Corp. -273.4 Thousand USD -3739.109%
SQZ Biotechnologies Company -79.46 Million USD 86.791%
Intellipharmaceutics International Inc. -2.89 Million USD -262.89%
Evofem Biosciences, Inc. 52.97 Million USD 119.812%
Santhera Pharmaceuticals Holding AG 65.13 Million USD 116.115%
Propanc Biopharma, Inc. -1.82 Million USD -476.547%
Marizyme, Inc. -65.34 Million USD 83.938%
Genus plc 7.9 Million USD 232.863%
Pharming Group N.V. -10.54 Million USD 0.491%
Therapeutic Solutions International, Inc. -2.16 Million USD -383.737%
CNBX Pharmaceuticals Inc. -3.71 Million USD -182.899%
Nymox Pharmaceutical Corporation -8.84 Million USD -18.682%
ContraFect Corporation -65.15 Million USD 83.89%
RegeneRx Biopharmaceuticals, Inc. -1.72 Million USD -507.611%
IMV Inc. -36.48 Million USD 71.232%
AXIM Biotechnologies, Inc. -8.05 Million USD -30.231%
ONE Bio Corp. 8.67 Million USD 220.971%
RVL Pharmaceuticals plc -51.69 Million USD 79.695%
Mesoblast Limited -87.95 Million USD 88.067%
MultiCell Technologies, Inc. -380.07 USD -2761549.696%
Arno Therapeutics, Inc. - USD Infinity%
Emmaus Life Sciences, Inc. -3.73 Million USD -181.173%
Genscript Biotech Corporation -95.47 Million USD 89.007%
Neon Bloom, Inc. -632.4 Thousand USD -1559.723%
Mosaic ImmunoEngineering Inc. -2.38 Million USD -340.856%
Nanobac Pharmaceuticals, Incorporated -6.57 Million USD -59.611%
Biomind Labs Inc. -1.21 Million USD -764.369%
Provectus Biopharmaceuticals, Inc. -3.1 Million USD -238.394%
Oncotelic Therapeutics, Inc. -7.9 Million USD -32.811%
Skye Bioscience, Inc. -37.64 Million USD 72.118%
GlobeStar Therapeutics Corporation -1.94 Million USD -438.474%
VioQuest Pharmaceuticals, Inc. -10.89 Million USD 3.632%
THC Farmaceuticals, Inc. -14.97 Thousand USD -69986.819%
PsyBio Therapeutics Corp. -4.88 Million USD -114.819%
Arch Therapeutics, Inc. -6.98 Million USD -50.314%
Sienna Biopharmaceuticals, Inc. - USD Infinity%
Acro Biomedical Co., Ltd. -15.87 Million USD 33.867%
Accustem Sciences Inc. -3.74 Million USD -180.166%
EV Biologics, Inc. -1.26 Million USD -728.342%
Q BioMed Inc. -2.05 Million USD -411.488%
GB Sciences, Inc. -1.36 Million USD -670.829%
Alpha Cognition Inc. -13.77 Million USD 23.789%
CSL Limited 2.64 Billion USD 100.397%
Agentix Corp. -1.37 Million USD -663.798%
American Oriental Bioengineering, Inc. -59.72 Million USD 82.426%
Enzolytics Inc. -2.17 Million USD -382.178%
TetraLogic Pharmaceuticals Corporation - USD Infinity%
Resverlogix Corp. -3.61 Million USD -190.754%
Nuo Therapeutics, Inc. -3.17 Million USD -230.961%
MetaStat, Inc. - USD Infinity%
Curative Biotechnology, Inc. -5.81 Million USD -80.432%
argenx SE -295.05 Million USD 96.443%
Northwest Biotherapeutics, Inc. -62.59 Million USD 83.233%
HST Global, Inc. -146.21 Thousand USD -7078.854%
Enzon Pharmaceuticals, Inc. 98 Thousand USD 10810.41%
Wesana Health Holdings Inc. -1.75 Million USD -498.152%
Halberd Corporation -79.67 Thousand USD -13073.606%
Endonovo Therapeutics, Inc. 6.92 Million USD 251.579%
Inhibitor Therapeutics, Inc. -3.02 Million USD -246.852%
Zenith Capital Corp. -10.59 Million USD 0.942%
RespireRx Pharmaceuticals Inc. -3.97 Million USD -164.189%
GeneThera, Inc. - USD Infinity%
Sigyn Therapeutics, Inc. -4.14 Million USD -153.168%
AVAX Technologies, Inc. -6.41 Million USD -63.654%
WPD Pharmaceuticals Inc. -60.44 Thousand USD -17266.142%
Cotinga Pharmaceuticals Inc. -2 Million USD -423.471%
Ember Therapeutics, Inc. -23.24 Thousand USD -45060.494%
Anthera Pharmaceuticals, Inc. - USD Infinity%
Adynxx, Inc. - USD Infinity%
NovAccess Global Inc. -4.76 Million USD -120.084%
Helix BioMedix, Inc. -1.05 Million USD -893.905%
Capstone Therapeutics Corp. -3.81 Million USD -174.842%
Kadimastem Ltd -3.3 Million USD -217.355%
VitaSpring Biomedical Co. Ltd. - USD Infinity%
BioStem Technologies, Inc. -8.48 Million USD -23.732%
Oncology Pharma Inc. - USD Infinity%
Reve Technologies, Inc. -441.36 Thousand USD -2278.101%
Burzynski Research Institute, Inc. -1.33 Million USD -685.979%
LadRx Corporation 400.44 Thousand USD 2721.148%
Cell Source, Inc. -5.32 Million USD -97.252%
ProtoKinetix, Incorporated -415.47 Thousand USD -2426.289%
Regen BioPharma, Inc. 1.02 Million USD 1125.512%
Regen BioPharma, Inc. 1.02 Million USD 1125.512%
Affymax, Inc. -14.42 Million USD 27.231%
Mobile Lads Corp. -2.26 Million USD -363.758%
Itoco Inc. -1.86 Million USD -461.596%
Rasna Therapeutics, Inc. -4.44 Million USD -136.266%
Pathfinder Cell Therapy, Inc. -1.66 Million USD -528.892%
International Stem Cell Corporation -131 Thousand USD -7912.368%
CytoDyn Inc. -49.84 Million USD 78.941%
Claritas Pharmaceuticals, Inc. - USD Infinity%
NDT Pharmaceuticals Inc. -79.03 Thousand USD -13180.784%
NanoSphere Health Sciences Inc. -228.12 Thousand USD -4501.035%
Qrons Inc. -789.34 Thousand USD -1229.732%
Alseres Pharmaceuticals, Inc. -941.52 Thousand USD -1014.804%
SYBLEU INC -180.3 Thousand USD -5721.392%
Advanced Proteome Therapeutics Corporation - USD Infinity%
Nascent Biotech, Inc. -2.08 Million USD -402.768%
Rebus Holdings, Inc. -1.02 Million USD -929.039%
GlobeImmune, Inc. - USD Infinity%
ImmunoCellular Therapeutics, Ltd. -1.61 Million USD -550.832%
Predictive Technology Group, Inc. - USD Infinity%
ProText Mobility, Inc. -54.27 Thousand USD -19239.995%
Cardax, Inc. - USD Infinity%
VG Life Sciences Inc. -2.53 Million USD -314.829%
Kaleido Biosciences, Inc. - USD Infinity%
Advaxis, Inc. -48.07 Million USD 78.166%
Adhera Therapeutics, Inc. -2.11 Million USD -396.509%
RenovaCare, Inc. - USD Infinity%
Regnum Corp. -780.88 Thousand USD -1244.138%
Innovation Pharmaceuticals Inc. -3.16 Million USD -231.32%
Neutra Corp. -233.46 Thousand USD -4395.835%
Windtree Therapeutics, Inc. -20.29 Million USD 48.272%
PureTech Health plc -65.69 Million USD 84.023%
Coeptis Therapeutics, Inc. -21.26 Million USD 50.645%
IXICO plc -1.17 Million USD -791.019%
IntelGenx Technologies Corp. -9.92 Million USD -5.734%
Gelesis Holdings, Inc. -57.12 Million USD 81.627%
CSL Limited 2.64 Billion USD 100.397%
Cellectis S.A. -103.17 Million USD 89.827%